Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.

We are delighted to have Susan Galbraith, Vice President of Oncology at AstraZeneca and Rob Bristow, Director of MCRC and Chief Academic Officer at The Christie NHS Foundation Trust as Keynote Speakers.

View the programme and more information here